Health Communication Tool + SDoH Screening for Lung Cancer
Trial Summary
What is the purpose of this trial?
A multilevel lung screening intervention that pairs Social Determinants of Health (SDoH) screening and referral with a tailored health communication and decision support tool for lung screening has the potential to significantly impact lung screening uptake among at-risk individuals in the community, particularly among those who face barriers related to SDoH. In addition, findings will advance the understanding of effective strategies for improving lung screening and prevention efforts in non-traditional settings, with the ultimate goal of reducing the burden of lung cancer. As ways to support the realization of the public health benefit of lung cancer screening are considered, multiple strategies and venues to reach, and intervene, with screening-eligible is key. The goal of this study is to compare the effectiveness of a community-based lung screening educational tool paired with a social determinants of health (SDoH) screening assessment and referral process compared to a community-based lung cancer screening (LCS) educational tool alone as part of community outreach activities to improve (a) LCS rates (primary outcome); (b) intention to screen; and (c) individual-level potential drivers of LCS (health literacy, mistrust, stigma, fatalism, knowledge, health beliefs). It is hypothesized that providing SDoH screening and referral will result in higher levels of LCS, forward movement of intention to screen, and improved individual-level drivers of LCS.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Health Communication Tool + SDoH Screening for Lung Cancer?
Research shows that community-based educational interventions, like the Lung AIR program, can effectively increase knowledge and intention to complete lung cancer screening, especially when delivered one-on-one. Additionally, understanding social factors like income and geographic location can help tailor interventions to improve screening rates.12345
Is the Health Communication Tool + SDoH Screening for Lung Cancer safe for humans?
How does the Health Communication Tool + SDoH Screening for Lung Cancer treatment differ from other treatments for lung cancer?
This treatment is unique because it combines community-based lung cancer screening with a focus on social determinants of health (SDoH), which are factors like income and access to healthcare that can affect a person's health. It aims to improve lung cancer screening rates by addressing these broader social factors and using a health communication tool to engage patients.2371011
Eligibility Criteria
This trial is for individuals aged 50-80 who can consent, currently smoke or quit within the last 15 years, have a history of significant smoking (20 pack-years), and have never had lung cancer screening. They must speak and understand English. Those with previous lung screenings or diagnosed with lung cancer are excluded.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive a community-based lung cancer screening educational tool, with or without a social determinants of health screening assessment and referral process
Follow-up
Participants are monitored for lung cancer screening uptake and changes in individual-level drivers of lung cancer screening
Treatment Details
Interventions
- Current practice - Community-based lung cancer screening (LungTalk) (Behavioral Intervention)
- Social determinants of health screening assessment and referral process (Behavioral Intervention)